LONDON – Studies have shown that marijuana not only helps fight the symptoms of treating cancer but also the disease itself. THC, or tetrahydrocannabinol, often gets the credit for battling cancer cells, but a new study shows that THC isn’t working alone. The study conducted at St. George’s University of London, led by Dr. Wai Liu, examined six […]
Read More Anti-Cancer Properties of Medical Marijuana Revealed in its entirety on The Daily Chronic.
Want to stay up to date on marijuana reform & cannabis news worldwide? Visit The Daily Chronic - The Voice of the Reform Generation, the most comprehensive coverage of the cannabis community!
SOURCE: More Anti-Cancer Properties of Medical Marijuana Revealed by Marijuana Policy Project
. . . . . READ MOREOAKLAND, CA — Steep Hill Laboratories, Inc. and Halent Scientific, the nation’s two leading cannabis testing and research companies, are pleased to announce they will be merging to form the leading analytical cannabinoid testing and research facility. The merger marks yet another leap forward in the nascent field of cannabis research, testing, and technological innovation, marrying Steep Hill’s innovation and technical prowess with Halent Scientific’s formidable research capabilities.
“We’ve worked hard to maintain a position of leadership for Steep Hill in the fields of cannabis testing and analytics,” said David Lampach, CEO and co-founder of Steep Hill Laboratories, Inc. “With this merger, we’ve achieved a new level of expertise and research ability that will ensure that Steep Hill-Halent will remain at the forefront of these fields and will also open up new avenues for providing clients with world class research, consulting, and testing methodology to further advance the industry.”
At a time when states like Washington, Colorado, and Massachusetts are mandating testing for their emerging cannabis markets, quality control is becoming paramount to ensuring consumer safety and establishing optimized regulatory frameworks. The newly merged Steep Hill-Halent is now an industry powerhouse in these areas.
“It is, indeed, exciting for us to now have an avenue for our research and methods to reach a much wider clientele,” said Donald. . . . . READ MORE